NewAmsterdam Pharma Co N.V (NAMS) Other Non-Current Assets: 2022-2024
- NewAmsterdam Pharma Co N.V's Other Non-Current Assets rose 8502.15% to $8,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $8,000, marking a year-over-year increase of 8502.15%. This contributed to the annual value of $35,000 for FY2023, which is 77.56% down from last year.
- According to the latest figures from Q2 2024, NewAmsterdam Pharma Co N.V's Other Non-Current Assets is $8,000, which was down 50.00% from $16,000 recorded in Q1 2024.
- Over the past 5 years, NewAmsterdam Pharma Co N.V's Other Non-Current Assets peaked at $156,000 during Q4 2022, and registered a low of $93 during Q2 2023.
- In the last 3 years, NewAmsterdam Pharma Co N.V's Other Non-Current Assets had a median value of $16,000 in 2024 and averaged $43,019.
- Its Other Non-Current Assets has fluctuated over the past 5 years, first crashed by 77.56% in 2023, then soared by 8,502.15% in 2024.
- Quarterly analysis of 3 years shows NewAmsterdam Pharma Co N.V's Other Non-Current Assets stood at $156,000 in 2022, then tumbled by 77.56% to $35,000 in 2023, then skyrocketed by 8,502.15% to $8,000 in 2024.
- Its Other Non-Current Assets was $8,000 in Q2 2024, compared to $16,000 in Q1 2024 and $35,000 in Q4 2023.
